Dyne Therapeutics, Inc. DYN

16.03 (0.48) (2.91%) as of 25 Sep
Market cap
$3.1B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Current Ratio

+8 more quarters

13.47 22.25 19.92 12.02
Net Debt/EBITDA
6.09 8.29 6.53 3.78
Debt/Equity
0.14 0.15 0.18 0.30
Free Cash Flow per Share
(0.64) (0.87) (0.88) (0.80)
Book value per Share
4.88 7.57 5.24 4.24
Free Cash Flow
(91.17) (112.32) (145.14) (131.80)
Other line items

Show all line items

Columns are period end dates